Literature DB >> 2784776

Qualitative differences in faecal alpha-1-antitrypsin in patients with Crohn's disease.

J F Colombel, C Mizon, M Balduyck, A Cortot.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2784776      PMCID: PMC1378312          DOI: 10.1136/gut.30.2.279

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  3 in total

1.  Qualitative study of fecal alpha 1-proteinase inhibitor in normal subjects and patients with Crohn's disease.

Authors:  C Mizon; C Becuwe; M Balduyck; J F Colombel; A Cortot; J Mizon; P Degand
Journal:  Clin Chem       Date:  1988-11       Impact factor: 8.327

2.  Fecal alpha 1-antitrypsin measurement: an indicator of Crohn's disease activity.

Authors:  S Meyers; A Wolke; S P Field; E J Feuer; J W Johnson; H D Janowitz
Journal:  Gastroenterology       Date:  1985-07       Impact factor: 22.682

3.  Faecal alpha-1-antitrypsin and excretion of 111indium granulocytes in assessment of disease activity in chronic inflammatory bowel diseases.

Authors:  W Fischbach; W Becker; J Mössner; W Koch; C Reiners
Journal:  Gut       Date:  1987-04       Impact factor: 23.059

  3 in total
  1 in total

1.  Structural heterogeneity of faecal alpha 1 antitrypsin shown by immunoblot analysis in patients with Crohn's disease.

Authors:  F Boege; W Fischbach
Journal:  Gut       Date:  1991-05       Impact factor: 23.059

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.